Interestingly, in addition to loss of NKA activity, a reduction or deficiency in mAChR have also been implicated in the pathophysiology of many major diseases of the CNS including schizophrenia [502], bipolar and major depression [503], Alzheimer’s disease [504] and ADHD [505]. This evidence concerns the gene TAC1 and early-onset autosomal dominant Alzheimer disease.